Mark Forman compensation by year
Ventyx Biosciences Summary Compensation Table · the one fiscal year held| Component | FY2024 |
|---|---|
| Salary | $188,165 |
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $556,500 |
| Non-equity incentive | $192,800 |
| Pension and deferred compensation | $0 |
| All other | $0 |
| Total | $937,465 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ventyx Biosciences, Inc. DEF 14A filed April 23, 2025, accession 0000950170-25-057384, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Ventyx Biosciences, Inc. filed document, accession 0000950170-25-057384. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 350,000 | — | $1.95 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Ventyx Biosciences, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Ventyx Biosciences’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Matthew Moore | Chief Operating Officer | $1,918,110 |
| Raju Mohan | Chief Executive Officer, President and Director | $1,283,015 |
| Martin Auster | Former Chief Financial Officer | $995,179 |
| Mark Forman · this page | Chief Medical Officer | $937,465 |
The full Ventyx Biosciences compensation record
free company briefThis page is one person within Ventyx Biosciences's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Ventyx Biosciences's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Ventyx Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order VTYX
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.